Pharmaceutical logistics in Malaysia runs on three legal layers: the product must be registered with the Drug Control Authority (MAL number), the importing and wholesaling companies must hold an Import Licence and/or Wholesaler's Licence issued under the Control of Drugs and Cosmetics Regulations 1984, and premises and transport must comply with Malaysia's Guideline on Good Distribution Practice. Licences are issued only to companies registered in Malaysia, are typically valid until 31 December of the year of issue (or the period the licence specifies), and an Import Licence lists the specific registered products it covers. Time- and temperature-sensitive products additionally fall under NPRA's cold chain requirements and inspections.
A note on terms: NPRA officially calls the holder of a product registration the Product Registration Holder (PRH). Throughout RHMI's guides we use the equivalent international term, Marketing Authorisation Holder (MAH) - they mean the same party.
The sequence: what has to exist before the first shipment
A common planning mistake is to treat logistics as a freight question. In Malaysia it is a licensing question first:
- Product registration. Outside narrow, specifically authorised exceptions (such as the regulator-controlled shortage routes), nothing can be imported for sale until the product is registered and carries a MAL number. How registration works.
- Import Licence. The importing company - a company registered in Malaysia - needs an Import Licence, and the specific product must be added to that licence's product list.
- Wholesaler's Licence. Wholesale supply runs under its own licence, held by the company that sells and moves the product to pharmacies, hospitals and other wholesalers.
- GDP compliance. Premises, storage and transport operate under the Guideline on Good Distribution Practice - inspected by NPRA and/or the Pharmacy Enforcement Division.
Steps 2-4 are why a foreign manufacturer cannot simply "ship to Malaysia": every layer requires a locally registered, licensed operator. The question is which operator - and what they control. Who should hold which role.
The licences, side by side
Under the Sale of Drugs Act 1952 and the Control of Drugs and Cosmetics Regulations 1984, NPRA's licence guideline (3rd Edition, March 2025) sets the requirements:
| Licence | Processing fee | Key requirements |
|---|---|---|
| Import Licence | RM 500 per application | Malaysian-registered company that is the registration holder or is appointed by the holder as importer; products registered with the DCA and added to the licence's product list; premises holding a local authority (PBT) business licence; premises meet GDP; a pharmacist with a Type A Poison Licence (Wholesale) if handling Scheduled Poisons |
| Wholesaler's Licence | RM 500 per application | Same pattern: Malaysian company, DCA-registered products, local-authority-licensed premises, GDP compliance, a pharmacist holding a Type A Poison Licence (Wholesale) for Scheduled Poisons |
| Manufacturer's Licence | RM 1,000 per application | For local manufacturing sites (outside the scope of this article) |
Details that surprise foreign teams:
- A licence is typically valid until 31 December of the year of issue (or the period specified in the licence) and must be renewed.
- A licence is tied to the company name and address and is not transferable. Change the premises, the company name or the store - you apply for a new licence.
- The Import Licence carries a product list. A newly registered product does not import itself: it must be added to the importer's licence before the first shipment.
- Business premises and the store must generally be in the same state (Selangor and Kuala Lumpur & Putrajaya are the exception).
- Applications, renewals and product additions all go through NPRA's QUEST system, with two named responsible persons, one of whom must be a Malaysian and contactable.
GDP: the standard everything runs on
Malaysia's Guideline on Good Distribution Practice (3rd Edition, 2018) covers the whole distribution chain: organisation and personnel, premises and facilities, documentation, operations, complaints and recalls, and transportation. Both importer and wholesaler premises must meet GDP as a licensing condition - it is not an optional quality badge but a statutory condition of holding the licence, verified through inspections.
GDP inspections are carried out by NPRA and/or the Pharmacy Enforcement Division. For a manufacturer choosing a Malaysian partner, the practical question is simple: can the partner show current GDP compliance and a satisfactory inspection status for the categories your product needs?
Cold chain: the stricter lane
Time- and temperature-sensitive products (TTSP) - vaccines, biologics, insulins and other refrigerated products (typically 2-8°C for refrigerated products; frozen at -18°C and below; ambient products per their label and stability data) - run under additional requirements: NPRA's supplementary guidance on the management of TTSP under the GDP guideline, cold chain facility inspections of importers and wholesalers that handle such products, and NPRA's published list of cold chain facilities found compliant at inspection - the status reflects the inspection date, so check how current it is.
For a foreign manufacturer this cuts both ways. It is a real operational bar: qualified storage, temperature monitoring, validated transport. And it is a real due-diligence tool: you can check whether your intended partner's facility appears on NPRA's cold chain compliance list - and how recent that inspection is - before you commit a temperature-sensitive product to it.
The flow in practice
Once the licences exist, a shipment moves like this: the manufacturer ships against the importer's order; the consignment clears customs in the name of the licensed importer whose licence lists the product; it moves into GDP-compliant storage; wholesale distribution then supplies pharmacies, hospitals, clinics and sub-wholesalers under the Wholesaler's Licence. For each consignment the importer also obtains the electronic import permit (ePermit via Dagang Net) where required. Documentation follows the product at every step - batch records, temperature logs where applicable, and full recall traceability; since 1 July 2026 the holder additionally carries mandatory shortage reporting obligations. The shortage reporting rules.
Who controls this chain - and why it matters
In the common setup one distributor is importer, wholesaler and registration holder at once. Operationally convenient; structurally it concentrates the licences, the logistics and your market access in one counterparty. The alternative RHMI operates: the registration is held independently, import runs through licensed, GDP-compliant partners under our coordination, and distribution goes through the channel that fits the product - for selected products RHMI takes on the commercial side itself. A commercial or logistics change then never touches the registration, because the holder role is contractually separate from the supply chain. Import & distribution as a service · The independent MAH role.
Frequently asked questions
Can a foreign company hold a Malaysian Import Licence?
No. Import and Wholesaler's Licences are issued to companies registered in Malaysia, with locally licensed premises. A foreign manufacturer supplies through a licensed local importer - its own subsidiary or a local partner.
How much does an Import Licence cost and how long is it valid?
The processing fee is RM 500 per application (non-refundable), and the licence is typically valid until 31 December of the year of issue, or the period specified in the licence. The real cost is operational: GDP-compliant premises, a responsible pharmacist where Scheduled Poisons are involved, and annual renewals.
Do we need both an Import Licence and a Wholesaler's Licence?
They cover different activities - bringing the product into Malaysia versus selling and moving it by wholesale. One company can hold both; the roles can also be split between an importer and separate wholesalers.
What is GDP and who checks it?
The Guideline on Good Distribution Practice (3rd Edition, 2018) - Malaysia's standard for storage, documentation, transport and recalls across the distribution chain. GDP compliance is a condition of the import and wholesale licences; inspections are carried out by NPRA and/or the Pharmacy Enforcement Division, including dedicated cold chain facility inspections for temperature-sensitive products.
Does my product need cold chain handling?
If it is time- and temperature-sensitive - vaccines, biologics, insulins and similar - yes: supplementary TTSP requirements apply on top of standard GDP, and NPRA inspects cold chain facilities specifically. Build this into partner selection, not after it.
Who are the main pharmaceutical logistics providers in Malaysia?
The large healthcare distribution and logistics operators include Zuellig Pharma, DKSH and Pharmaniaga, alongside specialised 3PLs and cold chain providers. Who moves the product is a separate decision from who holds your registration - our guide to Malaysian distributors covers how to choose without giving up control.
You might also find useful
- Independent MAH vs Distributor as MAH in Malaysia: The Decision Checklist
- Pharmaceutical import and distribution services in Malaysia by RHMI
- Importing and Distributing Pharmaceuticals in Malaysia: Licences and GDP
- Pharmaceutical Distributors in Malaysia: Top Companies and How to Choose
- Drug Registration in Malaysia: Process, Timeline and Requirements
- Sources:
- NPRA - Guideline on Application of Manufacturer's, Import and Wholesaler's Licenses for Registered Products, 3rd Edition, March 2025: npra.gov.my
- NPRA - Guideline on Good Distribution Practice, Third Edition, 2018: npra.gov.my
- NPRA - GDP and cold chain facility inspections (compliance status and Cold Chain Facilities List): npra.gov.my
- Legislation: Sale of Drugs Act 1952; Control of Drugs and Cosmetics Regulations 1984
- Editorial note: This page is general business and regulatory information for manufacturers evaluating Malaysia. It is not legal or regulatory advice. Fees, licence conditions and inspection practice are administrative details that change; confirm them against NPRA's current guidance before acting. Last reviewed against NPRA guidance: 24 September 2026.